Mark Tengler
16Patents
11h-index
7Co-inventors
61Inventor score
Filing activity: Feb 28, 2005 → Nov 25, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8318210B2 | Compositions and methods of making sustained release liquid formulations | Emerging Cross-Sectional Technologies | 42 | Active |
| US8709491B2 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Chemistry; Metallurgy | 30 | Active |
| US8840924B2 | Compositions and methods of making rapidly dissolving ionically masked formulations | Human Necessities | 28 | Active |
| US8470375B1 | Method of formulating and designing liquid drug suspensions containing ion exchange resin particles | Human Necessities | 19 | Active |
| US8313770B2 | Modifying drug release in suspensions of ionic resin systems | Human Necessities | 15 | Active |
| US9265737B2 | Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles | Chemistry; Metallurgy | 15 | Active |
| US9089496B2 | Compositions comprising methylphenidate complexed with ion-exchange resin particles | Chemistry; Metallurgy | 15 | Active |
| US9017731B2 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Chemistry; Metallurgy | 15 | Active |
| US9057675B2 | Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles | Human Necessities | 15 | Active |
| US9072680B2 | Compositions comprising methylphenidate complexed with ion-exchange resin particles | Chemistry; Metallurgy | 15 | Active |
| US8512759B1 | Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles | Human Necessities | 12 | Active |
| US9522120B2 | Compositions and methods of making sustained release liquid formulations | Emerging Cross-Sectional Technologies | 1 | Active |
| US11166947B2 | Effective dosing of a child for the treatment of ADHD with methylphenidate | Human Necessities | 1 | Active |
| US10874741B2 | Compound to treat Sjogren's syndrome | Human Necessities | 1 | Active |
| US11723979B2 | Compound to treat Sjogren's Syndrome | Human Necessities | 0 | Active |
| US9839619B2 | Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.